- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Aliquots are pre-aliquoted, commercially available drugs from the EU. Our aliquots thus contain therapeutic molecules manufactured by the original drug license holder and repackaged by Evidentic.
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
---|---|---|---|---|---|---|---|---|---|---|
CD80 , CD86 |
Fusion protein |
Orencia® |
25 mg/mL |
yes |
5 mg |
-80°C |
2023.02 |
223,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Amgevita® |
50 mg/mL |
– |
2 mg |
-80°C |
2021.12 |
304,00 € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
– |
4 mg |
-80°C |
2026.02 |
451,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Hulio® |
50 mg/mL |
– |
2 mg |
-80°C |
2023.02 |
304,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Hukyndra® |
100 mg/mL |
– |
2 mg |
-80°C |
2023.10 |
354,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Yuflyma® |
100 mg/mL |
– |
4 mg |
-80°C |
2024.02 |
354,00 € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
– |
4 mg |
-80°C |
2025.05 |
451,00 € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
yes |
4 mg |
-80°C |
2018.12 |
451,00 € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
yes |
4 mg |
-80°C |
2019.03 |
451,00 € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
yes |
4 mg |
-80°C |
2019.03 |
451,00 € |
||
TNF alpha |
Monoclonal Antibody |
Humira® |
100 mg/mL |
yes |
4 mg |
-80°C |
2019.07 |
451,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Idacio® |
50 mg/mL |
– |
2 mg |
-80°C |
2023.10 |
355,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Imraldi® |
50 mg/mL |
– |
2 mg |
-80 °C |
2023.10 |
304,00 € |
||
TNF alpha |
Biosimilar , Monoclonal Antibody |
Hyrimoz® |
50 mg/mL |
– |
2 mg |
-80°C |
2024.06 |
304,00 € |
||
PlGF , VEGF-A , VEGF-B |
Fusion protein |
Zaltrap® |
25 mg/mL |
– |
2 mg |
tba |
tba |
197,00 € |
||
PIGF , VEGF-A |
Fusion protein |
Eylea® |
40 mg/mL |
– |
0,8 mg |
tba |
tba |
1.293,00 € |
||
Clotting Factor IX |
Fusion protein |
Idelvion® |
200 IU/mL |
– |
25 IU |
-80°C |
2023.01 |
502,00 € |
||
IL-2RB |
Recombinant protein |
Proleukin® |
1,1 mg/mL |
– |
0,044 mg |
-80°C |
2024.07 |
347,00 € |
||
IL-2RB |
Recombinant protein |
Proleukin® |
1,1 mg/mL |
– |
0,044 mg |
-80°C |
2026.01 |
347,00 € |
||
CD52 |
Monoclonal Antibody |
Lemtrada® |
10 mg/mL |
– |
0,5 mg |
-80°C |
tba |
1.962,00 € |
||
Lysosomal glycogen |
Enzyme |
Myozyme® |
5 mg/mL |
– |
5 mg |
- 80°C |
2025.12 |
557,00 € |
||
Plasminogen activator (rt-PA) |
Glycoprotein |
Actilyse® |
1 mg/mL |
– |
0.4 mg |
-80°C |
2023.02 |
264,00 € |
||
EGFR , MET |
Bispecific Antibody |
Rybrevant® |
50 mg/ml |
– |
7 mg |
-80°C |
2027.04 |
376,00 € |
||
PD-L1 |
Monoclonal Antibody-Fc engineered |
Tecentriq® |
60 mg/mL |
yes |
12 mg |
-80°C |
2022.03 |
359,00 € |
||
Lysosomal glycogen |
Enzyme |
Nexviadyme® |
10 mg/mL |
– |
10 mg |
-80 °C |
05/2026 |
1.099,00 € |
||
PD-L1 |
Monoclonal Antibody |
Bavencio® |
20 mg/mL |
– |
2 mg |
-80°C |
2021.01 |
143,00 € |
||
CD80 , CD86 |
Fusion protein |
Nulojix® |
25 mg/mL |
– |
5 mg |
-80°C |
2025.01 |
221,00 € |
||
VEGF-A |
Monoclonal Antibody |
Zirabev® |
25 mg/mL |
– |
2 mg |
tba |
tba |
200,00 € |
||
VEGF-A |
Monoclonal Antibody |
Oyavas® |
25 mg/mL |
– |
2 mg |
tba |
tba |
197,00 € |
||
VEGF-A |
Monoclonal Antibody |
Alymsys® |
25 mg/mL |
– |
2 mg |
tba |
tba |
197,00 € |
Evidentic GmbH
Am Mühlenberg 10
14476 Potsdam | Germany